K200697

Substantially Equivalent

AtriCure cryoICE cryo-ablation probe (Cryo2), AAtriCure cryoICE cryoSPHERE cryoablation probe (CryoS, CryoS-L)

Applicant: AtriCure, Inc.
Product code: GXH
Advisory panel: Neurology
Date received: 2020-03-17
Decision date: 2020-12-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mason, OH, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.